Timothy Charles Bagguley

Search results

• 2022

  Erythropoietin stimulation agents significantly improves outcome in lower risk MDS

  Garelius, H. K. G., Smith, A. G., Bagguley, T. C., Taylor, A., Fenaux, P., Bowen, D., Symeonidis, A., MIttelmann, M., Stauder, R., Čermák, J., Sanz, G., Langemeijer, S., Malcovati, L., Germing, U., Itzykson, R., Guerci-Bresler, A., Culligan, D., Kotsianidis, I., Koinig, K. A. & van Marrewijk, C. & 3 others, Crouch, S., de Witte, T. & Hellstrom-Lindberg, E., Jun 2022, In: HemaSphere. 6, p. 69-70 S168.

  Research output: Contribution to journal › Meeting abstract › peer-review

  Open Access

  File
• 2018

  Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

  Hoeks, M., Bagguley, T., Roelofs, R., De Swart, L., Bowen, D., Symeonidis, A., van Marrewijk, C., Hellström-Lindberg, E., Tatic, A., Langemeijer, S., Culligan, D. J., Macheta, M., Garelius, H., Spanoudakis, M., Killick, S., Panagiotidis, P., Stanca Ciocan, O., Mills, J., Pottinger, B. & Ackroyd, S. & 5 others, Hall, C., Droste, J., Smith, A., Swinkels, D. W. & de Witte, T. M., 1 Nov 2018, In: Blood. 132, Suppl. 1, p. 4392 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• PCN351 - HEALTH-STATE UTILITY VALUES IN DIFFUSE LARGE B-CELL LYMPHOMA

  Wang, H., Manca, A., Crouch, S., Bagguley, T., Yu, G., Aas, E., Howell, D., Burton, C., Patmore, R., Roman, E. & Smith, A., 2018, In: Value in Health. 21, S3, 1 p., S74.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2017

  UK Utility Elicitation in Patients with Follicular Lymphoma

  Wang, H., Smith, A., Yu, G., Aas, E., Bagguley, T., Howell, D., Roman, E., Burton, C. & Patmore, R., 20 Oct 2017, In: Value in Health. 20, 9, p. A449 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2016

  Novel Targeted Therapies and Their Impact on Survival from Multiple Myeloma (MM) and Chronic Lymphocytic Leukaemia (CLL) in the Real World

  Smith, A. G., Bagguley, T. C., Roman, E., Rawstron, A. C., Bailey, J., Howell, D., Ashcroft, A. J., Burton, C., Cook, G. & Patmore, R., 2 Dec 2016, In: Blood. 128, 22, 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2015

  Chronic lymphocytic leukaemia treatment and outcome in the UK's population-based haematological malignancy research network

  Patmore, R., Smith, A. G., Bagguley, T. C., Howell, D., Bailey, J. R., Burton, C. & Roman, E., 9 Jun 2015, In: Hematological Oncology. 33, S1, 182.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2014

  Hepcidin and GDF15 Levels during the First 2 Years Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

  De Swart, L., Reiniers, C., Bagguley, T., van Marrewijk, C., Bowen, D., Cermak, J., Hellström-Lindberg, E., Tatic, A., Symeonidis, A., Huls, G. A., Smith, A. & de Witte, T., 1 Dec 2014, In: Blood. 124, 21, 3267.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2013

  Skeletal-Related Events In Myeloma: A Population-Based Study

  Ashcroft, A. J., Bagguley, T. C., Smith, A. G., Wang, H. I., Howell, D., Sayala, H. A., Cook, G., Jack, A., Patmore, R. & Roman, E., 15 Nov 2013, In: Blood. 122, 21, p. 3158-3158 3158.

  Research output: Contribution to journal › Meeting abstract › peer-review